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Abstract 
 
 
Objective: To compare the outcomes of planned vaginal versus planned caesarean delivery in a cohort 
of extremely obese women (BMI 50kg/m2 or greater). 
Design: A national cohort study using the UK Obstetric Surveillance System (UKOSS). 
Setting: All hospitals with consultant-led maternity units in the UK. 
Participants: 591 extremely obese women delivering in the UK between September 2007 and August 
2008.  
Methods: Prospective cohort identification through UKOSS routine monthly mailings.  
Main Outcome Measures: Anaesthetic, postnatal and neonatal complication rates.  
Results: After adjustment, there were no significant differences in anaesthetic, postnatal or neonatal 
complications between women with planned vaginal delivery and planned caesarean delivery, with the 
exception of shoulder dystocia (3% vs 0%, p=0.019). There were no significant differences in any 
outcomes in the subgroup of women who had no identified medical or antenatal complications. 
Conclusions: This study does not provide evidence to support a routine policy of caesarean delivery for 
extremely obese women on the basis of concern about higher rates of delivery complications, but would 
support a policy of individualised decision on mode of delivery based on a thorough assessment of 
potential risk factors for poor delivery outcomes.  
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Introduction 
Obesity is a growing global public health problem and a major contributor to the global burden of 
chronic disease and disability (1). Obesity has significant implications for the provision of maternity care 
both in relation to increased risks and complications for both mother and baby, and its association with 
an increased risk of caesarean delivery. A recent systematic review of 11 cohort studies reported that 
the risk of caesarean delivery was increased by 50% in women with a body mass index (BMI) of 30-35 
kg/m2 and more than double in women with a BMI>35 kg/m2 compared with women with a normal BMI 
(20-25 kg/m2) (2). Factors associated with the higher risk of caesarean delivery in obese women may 
include medical and pregnancy complications such as diabetes and pre-eclampsia, as well as poor 
uterine contractility (3) and concerns regarding the challenges of both general and regional anaesthesia 
in the emergency situation (4, 5). Anecdotally, there appears to be an increasing move to recommend 
planned caesarean delivery to avoid the perceived risks of emergency caesarean delivery in this group of 
women. However, earlier studies have highlighted increased morbidity and mortality associated with 
caesarean delivery in obese women, (6) longer operative times and length of hospital stay with blood 
loss and postoperative infective morbidity being greater (7, 8). Recent consensus standards on the 
management of women with obesity in pregnancy make no recommendation concerning caesarean 
delivery due to lack of evidence to inform advice (9). There is thus an urgent need for evidence to inform 
the development of clinical policy on the planned mode of delivery in this group of high risk women.  
The aim of this study was to investigate, using data from a UK national cohort of pregnant women with a 
BMI 50kg/m2 or over (10), the factors associated with mode of birth, and to compare the outcomes in 
women planned to deliver vaginally with those planned to deliver by caesarean.  
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Methods 
The cohort of extremely obese women was identified through the UK Obstetric Surveillance System 
(UKOSS) (11) between September 2007 and August 2008 and the methods of identification have been 
fully described elsewhere (10). The study included pregnant women who, at any point in pregnancy, had 
a body mass index (BMI) of 50kg/m2 or greater and had data for mode of birth and urgency of caesarean 
delivery (Figure 1).Women were divided into two groups based on the planned mode of delivery. 
Women who laboured or who had an induction of labour were included in the planned vaginal group 
and women who were delivered by caesarean without labour were included in the planned caesarean 
group. Characteristics were compared between the two groups using the Chi squared and Fishers exact 
tests. 
A multivariable logistic regression model was used to examine predictive factors for caesarean delivery. 
We developed a pragmatic model by including factors known from the literature to be associated with 
caesarean delivery particularly in obese women. The factors included were age, ethnicity, 
socioeconomic status based on occupation, previous caesarean delivery, diagnosed diabetes including 
current gestational diabetes, multiple pregnancy and BMI. Continuous variables were tested for 
departure from linearity by the inclusion of quadratic terms in the model and subsequent likelihood 
ratio testing on removal. Potential interactions between each variable and every other variable in the 
model were tested by the addition of interaction terms and subsequent likelihood ratio testing on 
removal. P<0.05 was considered evidence for significant interaction or departure from linearity. 
Unadjusted and adjusted odds ratios (OR) and 95% CIs were calculated. 
Outcomes were compared between the two groups in a further multivariable model, adjusting for 
potential confounders identified from the literature (pre-existing: diabetes, asthma, hypertension or 
endocrine disorder; and/or current: gestational diabetes, pre-eclampsia or a thromboembolic event in 
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this pregnancy, previous delivery by caesarean section). Neonatal outcomes were additionally adjusted 
for preterm delivery. A sensitivity analysis was conducted to explore the outcomes in the group of 
women who had no reported antenatal or medical complications (pre-existing: diabetes, asthma, 
hypertension or endocrine disorder; and/or current: gestational diabetes, pre-eclampsia or a 
thromboembolic event in this pregnancy ) by repeating the comparison of outcomes excluding women 
with any of these known complications.  
All analyses were carried out using STATA 10 software (StataCorp, College Station, TX). 
Results 
This analysis included 591 women who met the study inclusion criteria (Figure 1). The median BMI was 
55 with a range from 50.0 to 80. Of the 591 women, 174 (29.4%) were in the planned caesarean group 
and 417 (70.6%) were in the planned vaginal group. Of those who planned a vaginal delivery, 30.5% 
(n=127) went on to have a caesarean delivery. Characteristics of women according to planned mode of 
delivery are shown in Table 1. Women in the planned caesarean group were significantly older, of higher 
parity and more likely to have essential hypertension, previous hypertensive disorders of pregnancy, 
previous caesarean delivery, a multiple pregnancy or current gestational diabetes. In a logistic 
regression model, after controlling for age, ethnicity, socio-economic status and the other variables in 
Table 1, the factors associated with a significantly higher odds of actual caesarean delivery were a 
previous caesarean delivery and pre-existing diabetes or gestational diabetes and (Table 2). Of the 26 
women in the planned vaginal delivery group who had a previous caesarean delivery, only 9 (35%) 
delivered vaginally. There was a three-fold increase in the risk of caesarean delivery associated with 
multiple pregnancy; this was not statistically significant but it should be noted that due to small 
numbers this comparison has limited power to demonstrate statistical significance. 
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Admission to a neonatal intensive care unit was more likely in the infants born to women undergoing a 
planned caesarean delivery on univariate analysis. However, after adjustment, there were no significant 
differences in anaesthetic, postnatal or neonatal complications between women with planned vaginal 
delivery and planned caesarean delivery (Table 3), with the exception of shoulder dystocia. None of the 
13 infants born following shoulder dystocia were reported to have suffered permanent injury. The 
sensitivity analysis showed that there were no significant differences in any outcomes in the subgroup of 
women who had no identified medical or antenatal complications (Table 4), although it should be noted 
that there was a 66% lower risk of major maternal morbidity in the planned vaginal group (not 
statistically significant).  
Discussion 
This study did not identify any statistically significant differences in anaesthetic, maternal postnatal or 
neonatal complications according to planned mode of delivery in a national cohort of extremely obese 
women in the UK after adjusting for maternal medical and antenatal complications, other than in the 
occurrence of shoulder dystocia. None of the infants suffered permanent injury.  All the other 
complications examined, with the exception of postnatal wound complications, occurred less frequently 
in the planned vaginal group than the planned caesarean group, although again the differences were not 
statistically significant, possibly due to limited study power even in this national cohort study. When we 
examined the subgroup of women with no identified medical or antenatal complications, we were 
unable to identify any differences in any of the complications examined.  
Other studies addressing this issue are few and have focused particularly on planned mode of delivery in 
obese women who have undergone a previous caesarean delivery, reporting poorer outcomes amongst 
those undergoing a trial of labour compared with elective repeat caesarean delivery (12, 13). In contrast, 
we studied the entire group of extremely obese women and not a selected group, and after adjusting for 
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potential confounders did not demonstrate any differences in outcomes with the exception of shoulder 
dystocia without permanent injury. In our analysis of women without any documented medical or 
antenatal complications there were no significant differences, although it should be noted that even 
large national studies such as this have limited power to detect differences in rare outcomes. This study 
does not provide any evidence to support a policy of routine caesarean delivery for extremely obese 
women on the basis of concern of higher rates of delivery complications, but would support a policy of 
individualised decision on mode of delivery based on a thorough assessment of potential risk factors for 
poor delivery outcomes. Such a policy would be supported through guidance such as that available to 
inform the care of women undergoing birth after previous caesarean birth (14).  
The definition and accuracy of reporting of shoulder dystocia is an important factor in interpreting the 
incidence of shoulder dystocia. In practice, some clinicians only report a birth as involving shoulder 
dystocia if they had to employ specific manoeuvres to deliver the baby’s anterior shoulder. Others will 
record shoulder dystocia if there is any delay in the emergence of the shoulder following delivery of the 
head. It is possible in this cohort that the existence of the women’s extreme obesity ensured a high 
index of concern in the minds of the clinicians for shoulder dystocia and any difficulties delivering the 
baby was defined as shoulder dystocia. Nevertheless, 2.2% of babies were born following shoulder 
dystocia. This is higher than many other reported rates although studies report a wide variation in 
incidence. Unselected population studies in North America and the UK found a 0.6% incidence (15-17).  
Shoulder dystocia is known to increase with fetal macrosomia. For example, an incidence of 14.3% has 
been reported in babies with a birthweight of 4500-4750g, and 21.1% for those 4750-5000g in a 
population based study in California (18). In this cohort, nearly 10% of babies weighed 4500g or more at 
birth; over 60% of these were in the planned vaginal delivery group suggesting that more accurate 
assessment of fetal weight may be beneficial. Unfortunately, estimating fetal weight is particularly 
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challenging in women with a high BMI as conventional methods, such as ultrasound scanning in late 
pregnancy, are likely to be difficult, inaccurate and in some cases, not possible at all. Abdominal 
palpation and fundal height measurement are also not likely to be helpful in predicting the size of the 
baby. Other measures such an MRI scanning are also limited by the size of the machine and the cost and 
availability.  
One of the main concerns about caesarean delivery for women with extreme obesity has been the risk 
of anaesthetic complications in the emergency situation. A recent study of difficult and failed intubation 
in obstetric anaesthesia found that women whose tracheas proved difficult to intubate had a weight 
range of 50 to 140 kg (median 80 kg) while those in whom intubation was straightforward ranged from 
50 to 73 kg (median 57 kg) (19). In their logistic regression analysis however, a weight of 100 kg or more 
was not an independent predictor of a difficult intubation. This may have been due to the small sample 
size in the difficult intubation group (36 of 1095 patients) and the sole use of weight, rather than BMI. A 
study of failed intubation for obstetric anaesthesia is currently being conducted to investigate the role of 
BMI in failed intubation further (20). Anaesthetic complications were rare in our cohort, and there were 
no differences between the planned vaginal and planned caesarean groups.  
Randomised controlled trials in the context of uncommon pregnancy conditions such as extreme obesity 
are challenging and national cohort studies such as this provide high quality evidence in the absence of 
randomised controlled trials, as they are free from most of the biases of centre-based observational 
studies. Nevertheless, the study design does have limitations. We identified clear differences between 
the groups planned to deliver vaginally and those planned to have a caesarean delivery reflecting the 
clinical decision-making which underlies the choice of mode of delivery and we therefore adjusted for 
these in our analysis. It is likely, however, that there are other differences between the two groups 
which we have not identified and therefore have not been able to adjust for. UKOSS was also the only 
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source of data used in the absence of any other available source; however, previous studies using this 
system have suggested a high rate of case ascertainment (21-23). The study was conducted in a well 
developed health system and as such, the results cannot be generalised to less developed health 
systems. It is likely that the health care for this group of women in countries such as the USA, Australia 
and much of Europe will be similar and therefore the results are likely to be generalisable to these 
settings.  
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Table 1: Demographic characteristics, pregnancy events and complications by planned mode of birth 
 Planned vaginal 
delivery 
N=417 (%*) 
Planned caesarean 
delivery 
N=174 (%*) 
P value 
 
Parity 
 Primiparous 
 Multiparous 
 
162 (38.9) 
255 (61.1) 
 
40 (23.1) 
54 (76.9) 
 
 
<0.001 
Age 
 <35 years 
 >35 years 
 
322 (77.2) 
95 (22.8) 
 
112 (64.4) 
62 (35.6) 
 
 
0.001 
Ethnicity 
 White 
 Black and other minority 
groups 
 
366 (88.6) 
47 (11.4) 
 
147 (87.0) 
22 (13.0) 
 
 
0.579 
Socioeconomic group 
 Managerial/professional 
 Other 
 
288 (83.2) 
58 (16.8) 
 
112 (80.0) 
28 (20.0) 
 
 
0.397 
BMI    
 50-54 278 (66.7) 108 (62.1)  
 55-59 90 (21.6) 40 (23.0)  
 60-64 35 (8.4) 15 (8.6)  
 >65 14 (3.4) 11 (6.3) 0.423 
Previous medical conditions 
 Hypertension 
 Asthma 
 Endocrine disorders 
 Diabetes 
 Mental health problems 
 Polycystic ovarian syndrome 
 
19 (4.6) 
51 (12.2) 
13 (3.1) 
17 (4.1) 
41 (9.8) 
22 (5.3) 
 
19 (11.1) 
21 (12.1) 
9 (5.1) 
12 (6.9) 
19 (10.9) 
4 (2.3) 
 
0.004 
0.956 
0.229 
0.148 
0.690 
0.108 
Previous obstetric conditions 
 Gestational diabetes (GDM) 
 Pre-eclampsia or Pregnancy 
induced hypertension 
(PE/PIH) 
 
14 (3.4) 
 
39 (9.4) 
 
 
8 (4.6) 
 
26 (14.9) 
 
 
0.468 
 
0.048 
 
Composite antenatal medical risk 
factor** 
139 (33.3) 86 (49.4) <0.001 
 
Current obstetric conditions    
 Previous CS 26 (6.2) 74 (42.5) <0.001 
 Multiple pregnancy 6 (1.4) 11 (6.3) 0.001 
 PE/PIH 88 (21.1) 47 (27.0) 0.119 
 GDM  37 (8.9) 32 (18.4) 0.001 
 Thrombotic event 3 (0.7) 0 (0) 0.265 
*Percentages of those with data 
**Composite antenatal medical risk factor: one or more of the following: pre-existing diabetes, asthma, hypertension or 
endocrine disorder; and/or current gestational diabetes, pre-eclampsia or a thromboembolic event in this pregnancy 
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Table 2: Factors associated with actual delivery by caesarean in extremely obese women, irrespective of planned 
mode of delivery 
  Vaginal delivery CS Unadjusted Adjusted* 
  N=290 % N=301 % OR (95% CI) OR (95% CI) 
Age 
 <25 years 59 20.3 38 12.6 1.0 1.0 
 25-34 years 170 58.7 167 55.5 1.52 (0.96-2.41) 1.20 (0.68-2.13) 
 >35 years 61 21.0 96 31.9 2.44 (1.45-4.10) 1.50 (0.78-2.86) 
Ethnic group 
 White 253 87.9 260 88.4 1.0 1.0 
 All other groups 35 12.1 34 11.6 0.95 (0.57-1.56) 0.86 (0.46-1.60) 
SES status 
 Non-managerial 199 85.0 201 79.8 1.0 1.0 
 Managerial 35 15.0 51 20.2 1.44 (0.90-2.31) 1.65 (0.99-2.76) 
Previous CS 
 No 281 96.9 210 69.8 1.0 1.0 
 Yes 9 3.1 91 30.2 13.5 (6.67-27.46) 16.7 (7.06-39.7) 
Past or current diabetes (including GDM in this pregnancy) 
 No 258 89.0 240 79. 1.0 1.0 
 Yes 32 11.0 61 20.3 2.05 (1.29-3.25) 2.08 (1.20-3.59) 
BMI       
 <60 256 88.3 260 86.4 1.0 1.0 
 >60 34 11.7 41 13.6 1.19 (0.73-1.93) 1.14 (0.63-2.06) 
Multiple pregnancy       
 No 286 98.6 288 95.7 1.0 1.0 
 Yes 4 1.4 13 4.3 3.23 (1.04-10.02) 3.42 (0.85-13.79) 
*Adjusted for all other factors in the model. 
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Table 3: Anaesthetic, postnatal and neonatal complications by planned mode of birth 
 Vaginal  
N=417 (%) 
Caesarean  
N=174 (%) 
Unadjusted 
OR  
(95% CI)  
 
Adjusted OR  
(95% CI) ** 
 
Caesarean delivery     
 127 (30.5) 174 (100) NA NA 
Anaesthetic     
 Failure or problems with 
regional anaesthesia 
35 (8.4) 18 (10.3) 0.79 (0.44-
1.44) 
0.72 (0.37-1.39) 
 General anaesthetic for 
delivery 
22 (5.3) 15 (8.6) 0.59 (0.30-
1.17) 
0.55 (0.26-1.16) 
Maternal postnatal     
 Post operative wound 
infection or other wound 
complication† 
33 (26.2) 38 (22.4) 1.23 (0.72-
2.11) 
1.20 (0.68-2.13) 
 ICU admission 9 (2.2) 6 (3.5) 0.61 (0.22-
1.75) 
0.62 (0.19-2.07) 
 Major maternal morbidity* 18 (4.3) 11 (6.3) 0.67 (0.31-
1.45) 
0.53 (0.23-1.24) 
Neonatal     
 Birthweight 4500g or greater 35 (8.4) 22 (12.7) 0.63 (0.36-
1.11) 
0.60 (0.32-1.12) 
 Shoulder dystocia 13 (3.1) 0 (0) ∞ (1.44-∞) NC 
 Neonatal Intensive care unit 
admission 
34 (8.3) 27 (15.5) 0.49 (0.29-
0.84) 
0.67 (0.34-1.30) 
 Neonatal death 2 (0.5) 1 (0.6) 0.85 (0.08-9.4) 1.08 (0.09-13.2) 
†Denominator is women who had a caesarean delivery. 
*Composite score including one or more of the following: intraoperative or postpartum haemorrhage, thromboembolic event, 
septicaemia, septic shock and/or admission to an intensive care unit.  
**
Adjusted for the presence of one or more of the following: pre-existing diabetes, asthma, hypertension or endocrine disorder; 
and/or gestational diabetes, pre-eclampsia or a thromboembolic event in this pregnancy, previous delivery by caesarean 
section. Neonatal outcomes additionally adjusted for preterm delivery (gestation less than 37 completed weeks at birth) 
NA Not applicable, NC Not calculable due to zero cells 
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Table 4: Sensitivity analysis to examine anaesthetic, postnatal and neonatal complications by planned mode of 
birth excluding women with known antenatal complications*** 
 Vaginal  
N=288 (%) 
Abdominal  
N=88 (%) 
Unadjusted 
OR  
(95% CI)  
 
Adjusted OR  
(95% CI) ** 
 
Caesarean delivery     
 76 (27.3) 88 (100) NA NA 
Anaesthetic     
 Failure or problems with 
regional anaesthesia 
19 (6.8) 8 (9.1) 0.73 (0.31-
1.74) 
0.67 (0.25-1.78) 
 General anaesthetic for 
delivery 
13 (4.7) 6 (6.8) 0.67 (0.25-
1.82) 
0.62 (0.20-1.92) 
Maternal postnatal     
 Post operative wound 
infection or other wound 
complication† 
19 (25.0) 15 (17.7) 1.56 (0.73-
3.33) 
1.43 (0.64-3.22) 
 ICU admission 5 (1.8) 3 (3.5) 0.51 (0.12-
2.19) 
0.29 (0.07-1.25) 
 Major maternal morbidity* 10 (3.6) 5 (5.7) 0.62 (0.21-
1.86) 
0.34 (0.11-1.04) 
Neonatal     
 Birthweight 4500g or greater 21 (7.6) 11 (12.6) 0.45 (0.26-
1.22) 
0.19 (0.32-1.05) 
 Shoulder dystocia 5 (1.8) 0 (0) ∞ (0.40-∞) NC 
 Neonatal Intensive care unit 
admission 
18 (6.5) 7 (8.0) 0.81 (0.33-
2.00) 
0.79 (0.28-2.25) 
 Neonatal death 2 (0.5) 0 (0) ∞ (0.16-∞) NC 
†Denominator is women who had a caesarean delivery. 
*Composite score including one or more of the following: intraoperative or postpartum haemorrhage, thromboembolic event, 
septicaemia, septic shock and/or admission to an intensive care unit.  
**
Adjusted for previous delivery by caesarean section. Neonatal outcomes additionally adjusted for preterm delivery (gestation 
less than 37 completed weeks at birth) 
***The presence of one or more of the following: pre-existing diabetes, asthma, hypertension or endocrine disorder; and/or 
gestational diabetes, pre-eclampsia or a thromboembolic event in this pregnancy. 
NA Not applicable, NC Not calculable due to zero cells 
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